GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Nath Bio-Genes (India) Ltd (BOM:537291) » Definitions » Change In Receivables

Nath Bio-Genes (India) (BOM:537291) Change In Receivables : ₹0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Nath Bio-Genes (India) Change In Receivables?

Nath Bio-Genes (India)'s change in receivables for the quarter that ended in Mar. 2024 was ₹0 Mil. It means Nath Bio-Genes (India)'s Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Nath Bio-Genes (India)'s change in receivables for the fiscal year that ended in Mar. 2024 was ₹-11 Mil. It means Nath Bio-Genes (India)'s Accounts Receivable increased by ₹11 Mil from Mar. 2023 to Mar. 2024 .

Nath Bio-Genes (India)'s Accounts Receivable for the quarter that ended in Mar. 2024 was ₹943 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Nath Bio-Genes (India)'s Days Sales Outstanding for the three months ended in Mar. 2024 was 199.95.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Nath Bio-Genes (India)'s liquidation value for the three months ended in Mar. 2024 was ₹1,559 Mil.


Nath Bio-Genes (India) Change In Receivables Historical Data

The historical data trend for Nath Bio-Genes (India)'s Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nath Bio-Genes (India) Change In Receivables Chart

Nath Bio-Genes (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -146.03 -228.25 -572.11 -326.64 -11.47

Nath Bio-Genes (India) Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nath Bio-Genes (India) Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nath Bio-Genes (India)  (BOM:537291) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Nath Bio-Genes (India)'s Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=943.086/430.38*91
=199.95

2. In Ben Graham's calculation of liquidation value, Nath Bio-Genes (India)'s accounts receivable are only considered to be worth 75% of book value:

Nath Bio-Genes (India)'s liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2403.489-2703.119+0.75 * 943.086+0.5 * 2303.091
=1,559

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nath Bio-Genes (India) Change In Receivables Related Terms

Thank you for viewing the detailed overview of Nath Bio-Genes (India)'s Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Nath Bio-Genes (India) (BOM:537291) Business Description

Traded in Other Exchanges
Address
Nath House, Nath Road, Chhatrapati Sambhajinagar, MH, IND, 431005
Nath Bio-Genes (India) Ltd is engaged in the business of production, processing, and marketing of Hybrid and GM seeds. The company has a product range of field crops, vegetable crops, and micronutrient supplements. It has developed products across verticals of cotton, paddy, mustard, maize, okra, tomato, gourds, chili, and crop nutrition supplements. The operating segments of the group are Agriculture activities and Trading activities, of which a majority of revenue is derived from the Agriculture activities segment. Geographically, the group has a business presence in India and other countries, of which key revenue is generated within India.

Nath Bio-Genes (India) (BOM:537291) Headlines

No Headlines